Pacific Biosciences of California Inc. (PACB)

7.53
0.01 0.07
NASDAQ : Health Technology
Prev Close 7.53
Open 7.55
Day Low/High 7.48 / 7.56
52 Wk Low/High 2.02 / 7.84
Volume 3.08M
Avg Volume 3.84M
Exchange NASDAQ
Shares Outstanding 148.90M
Market Cap 1.15B
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
BGI Adopts Single Molecule, Real-Time Sequencing From Pacific Biosciences

BGI Adopts Single Molecule, Real-Time Sequencing From Pacific Biosciences

PacBio RS II Systems to Be Used for Projects Such As De Novo Genome Assembly, Whole-Genome Methylation Analysis and Transcript Isoform Characterization

Pacific Biosciences Introduces New Solutions For Comprehensive And Efficient Targeted Sequencing And Multiplexing Of Samples

Pacific Biosciences Introduces New Solutions For Comprehensive And Efficient Targeted Sequencing And Multiplexing Of Samples

Collaboration With Roche NimbleGen Yields Protocols for Target Enrichment of 6 kb Fragments; Sample Barcoding Facilitates Multiplexing, Saving Time and Cost

First Week of May 15th Options Trading For Pacific Biosciences of California (PACB)

First Week of May 15th Options Trading For Pacific Biosciences of California (PACB)

Investors in Pacific Biosciences of California Inc saw new options begin trading this week, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PACB options chain for the new May 15th contracts and identified one put and one call contract of particular interest.

Short Interest Moves 12.2% Higher For PACB

Short Interest Moves 12.2% Higher For PACB

The most recent short interest data has been released by the NASDAQ for the 03/13/2015 settlement date, which shows a 907,143 share increase in total short interest for Pacific Biosciences of California Inc , to 8,330,881, an increase of 12.22% since 02/27/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

PACB: Insiders vs. Shorts

PACB: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 02/13/2015 settlement date, and Pacific Biosciences of California Inc is one of the most shorted stocks of the Russell 3000, based on 7.26 "days to cover" versus the median component at 5.17. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Insider Trading Alert - MFSF, FEYE And PACB Traded By Insiders

Insider Trading Alert - MFSF, FEYE And PACB Traded By Insiders

Stocks with insider trader activity include MFSF, FEYE and PACB

Pacific Biosciences Enables Reference-Quality De Novo Human Genome Assemblies

Pacific Biosciences Enables Reference-Quality De Novo Human Genome Assemblies

Researchers at AGBT Conference Present PacBio Data for J. Craig Venter, Asian Genome Reference, Ashkenazi Jewish Reference, and Breast Cancer Genome

Pacific Biosciences Of California (PACB) Weak On High Volume Today

Pacific Biosciences Of California (PACB) Weak On High Volume Today

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a weak on high relative volume candidate

Apple and Fed Move Market

Energy stocks take a hit; bonds climb after Fed news.

Interesting PACB Put And Call Options For September 18th

Interesting PACB Put And Call Options For September 18th

Investors in Pacific Biosciences of California Inc saw new options become available this week, for the September 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Pacific Biosciences Customers Present Work On Complex De Novo Genomes And Genome Annotation At The International Plant & Animal Genome XXIII Conference

Pacific Biosciences Customers Present Work On Complex De Novo Genomes And Genome Annotation At The International Plant & Animal Genome XXIII Conference

"Most Interesting Genome in the World" SMRT Grant Program Announced, Last Year's Winner Showcased Alongside Other Important Crop and Livestock Genomic Advancement Efforts

First Week of PACB February 20th Options Trading

First Week of PACB February 20th Options Trading

Investors in Pacific Biosciences of California Inc saw new options become available this week, for the February 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PACB options chain for the new February 20th contracts and identified one put and one call contract of particular interest.

Pacific Biosciences Appoints Kathy Ordonez To Board Of Directors

Pacific Biosciences Appoints Kathy Ordonez To Board Of Directors

Industry Veteran Previously Served as SVP at Quest Diagnostics and CEO of Celera and of Roche Molecular Systems

Pacific Biosciences Of California (PACB) Flagged As Strong On High Volume

Pacific Biosciences Of California (PACB) Flagged As Strong On High Volume

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a strong on high relative volume candidate

Researchers Use PacBio Sequencing To Create More Complete Human Genome Reference And Discover New Forms Of Structural Variation; Paper Published In Nature

Researchers Use PacBio Sequencing To Create More Complete Human Genome Reference And Discover New Forms Of Structural Variation; Paper Published In Nature

Several New Studies Highlight Growing Trend of Scientists Using SMRT(R) Sequencing Technology to Reveal Complexity and Medically Relevant Information in the Human Genome

New DNA Sequencing Facility Established In China Based On PacBio's SMRT Sequencing Platform

New DNA Sequencing Facility Established In China Based On PacBio's SMRT Sequencing Platform

PacBio RS II Systems Will Support Sequencing Services for Human, Animal, Plant and Bacterial Applications

Strong On High Volume: Pacific Biosciences Of California (PACB)

Strong On High Volume: Pacific Biosciences Of California (PACB)

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a strong on high relative volume candidate

Commit To Purchase Pacific Biosciences of California At $5, Earn 39.9% Annualized Using Options

Commit To Purchase Pacific Biosciences of California At $5, Earn 39.9% Annualized Using Options

Investors eyeing a purchase of Pacific Biosciences of California Inc stock, but cautious about paying the going market price of $5.63/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $5 strike, which has a bid at the time of this writing of 35 cents.

Pacific Biosciences Releases New DNA Sequencing Chemistry To Enhance Read Length And Accuracy For The Study Of Human And Other Complex Genomes

Pacific Biosciences Releases New DNA Sequencing Chemistry To Enhance Read Length And Accuracy For The Study Of Human And Other Complex Genomes

New Chemistry Boosts Accuracy and Increases Average Read Length to 10,000 to 15,000 Bases Accelerating Innovative Genomic Research

Human Longevity Inc. Adds PacBio(R) Sequencing To Enable Additional Insight Into Human Genetic Variation

Human Longevity Inc. Adds PacBio(R) Sequencing To Enable Additional Insight Into Human Genetic Variation

Purchase of Two PacBio RS II Sequencing Systems Will Be Used to Help Build HLI's Genotype/Phenotype Database

Macrogen Selects Single Molecule, Real-Time Sequencing For High-Quality De Novo Asian Human Reference Genomes

Macrogen Selects Single Molecule, Real-Time Sequencing For High-Quality De Novo Asian Human Reference Genomes

Purchase of Two PacBio RS II Sequencing Systems Will Support Global Sequencing Service Business for Human, Animal, Plant and Bacterial Applications

Single Molecule, Real-Time (SMRT) DNA Sequencing Tracks Infectious Disease Pathogens More Effectively Than Short-Read Technologies

Single Molecule, Real-Time (SMRT) DNA Sequencing Tracks Infectious Disease Pathogens More Effectively Than Short-Read Technologies

Series of Recent Publications Highlight Unique Advantages of Long-Read SMRT Sequencing for Understanding Spread of Antibiotic Resistance

TheStreet Quant Rating: D- (Sell)